Clinical Trials Directory

Trials / Conditions / Biochemical Recurrence of Malignant Neoplasm of Prostate

Biochemical Recurrence of Malignant Neoplasm of Prostate

9 registered clinical trials studyying Biochemical Recurrence of Malignant Neoplasm of Prostate — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNon-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (
NCT07483658
CHU de Quebec-Universite LavalN/A
RecruitingA Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusiv
NCT06859203
Technical University of Munich—
RecruitingDiagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
NCT06657131
Heinrich-Heine University, Duesseldorf—
CompletedCopper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer
NCT06235099
Curium US LLCPhase 3
RecruitingPROCARE - PROstate Cancer Real World Evidence Registry
NCT06835218
UroTrials Company (GmbH)—
Recruiting68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
NCT05847348
Telix Pharmaceuticals (Innovations) Pty LimitedPhase 3
UnknownSRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy
NCT04931979
Prof. Dr. med. Christian GratzkePhase 2
Completed64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)
NCT05407311
Clarity Pharmaceuticals LtdPhase 2
Completed64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)
NCT05249127
Clarity Pharmaceuticals LtdPhase 1 / Phase 2